Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 536-543

  Osmond, Dennis H ^a   Chin, Daniel P ^b   Glassroth, Jeffrey ^b   Kvale, Paul A ^b   Wallace, Jeanne M ^b   Rosen, Mark J ^b   Reichman, Lee B ^b   Poole, W Kenneth ^b   Hopewell, Philip C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0032860518     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598629     Document Type: Article

References (24)

1. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11-year follow up study. BMJ 1990;301:1183-8.
2. Selwyn PA, Alcabes P, Hartell D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327:1697-703.
3. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8.
4. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
5. Wallace JM, Hansen NI, Lavange L, et al., the Pulmonary Complications of HIV Infection Study Group. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Am J Respir Crit Care Med 1997;155:72-80.
6. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus, N Engl J Med 1995,333:845-51.
7. Pulmonary Complications of HIV Infection Study Group, Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. J Clin Epidemiol 1993;46:497-507.
8. Centers for Disease Control. Revision of the case definition for acquired immunodeficiency syndrome for national reporting - United States. MMWR Morb Mortal Wkly Rep 1987;34:373-5.
9. Rothman KJ. Modern epidemiology, Boston: Little, Brown and Company, 1986:153-75.
10. Harrell FE, Lee KL. Verifying assumptions of the Cox proportional hazards model. In: Proceedings of the 11th Annual SAS Users Group International Conference. Cary, NC: SAS Institute, 1986.
11. Chaisson RE, Gallant JE, Keruly JC, Moore RD, Impact of opportunistic disease on survival in patients with HIV infection. AIDS 1998;12: 29-33.
12. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
13. McGowan I, Radford-Smith G, Jewell DP. Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994;8:1569-75.
14. Palenicek JP, Graham MH, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr 1995; 10:366-73.
15. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;1334: 1222-30.
16. Claydon EJ, Bennett J, Gor D, Forster SM. Transient elevation of serum HIV antigen levels associated with intercurrent infection. AIDS 1991; 5:113-4.
17. Donovan RM, Bush CE, Markowitz NP, Baxa DM, Saravolatz LD. Changes in virus load markers during AIDS-associated opportunistic disease in human immunodeficiency virus-infected persons. J Infect Dis 1996;174:401-3.
18. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995;333: 751-6.
19. + T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical research in AIDS. Clin Infect Dis 1996;22:513-20.
20. Perneger TV, Sudre P, Lundgren JD, Hirschel B, for the AIDS in Europe Study Group. Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study of 17 European countries over 13 years. BMJ 1995;311:1468-71.
21. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-I1):1-19.
22. S.F. AIDS incidence and mortality. San Francisco: San Francisco Department of Public Health AIDS Office. January 1996.
23. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Am J Respir Crit Care Med 1996;155:60-6.
24. Gebo KA, Moore RD, Keruly JC, Chaisson RE, Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996:173:857-62.